Similar to the observations from HCC cells, overexpression of FGF19 suppressed E-cadherin expression (Figure 3A and 3B) and promoted EMT in HL7702 normal liver cells (Figure 3C), implicating that FGF19-induced EMT may also play a critical role in cirrhotic liver diseases. Here, FGF19 is linked to hepatocellular carcinoma.